We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current INMB market cap is 169.22M. The company's latest EPS is USD -1.6651 and P/E is -5.66.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 97k | 38k | 46k | 43k | 28k |
Operating Income | -5.64M | -6.42M | -6.41M | -8.53M | -8.38M |
Net Income | -5.83M | -6.54M | -6.5M | -8.56M | -8.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.54M | 11k | 181k | 374k | 155k |
Operating Income | -7.76M | -12.23M | -29.15M | -25.95M | -29.74M |
Net Income | -7.68M | -12.1M | -30.34M | -27.3M | -30.01M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 81.8M | 73.98M | 69.72M | 62.7M | 57M |
Total Liabilities | 21.69M | 18.68M | 19.07M | 17.97M | 18.86M |
Total Equity | 60.1M | 55.3M | 50.65M | 43.93M | 37.34M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 24.47M | 40.66M | 99.95M | 81.8M | 57M |
Total Liabilities | 860k | 1.9M | 19.72M | 21.69M | 18.86M |
Total Equity | 23.61M | 38.75M | 80.23M | 60.1M | 37.34M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -22.69M | -1.14M | -4.32M | -8.58M | -11.98M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 729k | N/A | N/A | -1.73M | -4.23M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.38M | -8.94M | -28.5M | -22.69M | -11.98M |
Investing | N/A | N/A | -15M | N/A | N/A |
Financing | 12.21M | 23.9M | 96.36M | 729k | -4.23M |
Market Cap | 169.22M |
Price to Earnings Ratio | -5.66 |
Price to Sales Ratio | 1.1k |
Price to Cash Ratio | 4.74 |
Price to Book Ratio | 4.45 |
Dividend Yield | - |
Shares Outstanding | 18.02M |
Average Volume (1 week) | 77.11k |
Average Volume (1 Month) | 95.25k |
52 Week Change | 17.96% |
52 Week High | 14.74 |
52 Week Low | 6.5001 |
Spread (Intraday) | 1.22 (12.45%) |
Company Name | INmune Bio Inc |
Address |
701 s carson st carson city, nevada 89701 |
Website | https:// |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions